Australia - Inggris - Department of Health (Therapeutic Goods Administration)

avallon pharmaceuticals pty ltd - atorvastatin calcium trihydrate, quantity: 10.845 mg (equivalent: atorvastatin, qty 10 mg) - tablet, film coated - excipient ingredients: magnesium stearate; calcium carbonate; lactose monohydrate; croscarmellose sodium; hyprolose; microcrystalline cellulose; polysorbate 80; euphorbia antisyphilitica; titanium dioxide; macrogol 8000; hypromellose; purified talc; purified water; sodium chloride; dimeticone 100; benzoic acid; sorbic acid; methylcellulose; polysorbate 65; glyceryl distearate; silicon dioxide; dimeticonol; peg-4 stearate - as an adjunct to diet for the treatment of patients with hypercholesterolaemia. prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy and alcoholism) should be identified and treated.,indicated in hypertensive patients with multiple risk factors for coronary heart disease (chd), which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic chd (see clinical trials, prevention of cardiovascular disease) to reduce the risk of non-fatal myocardial infarction and non-fatal stroke. these effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.

Panama - Inggris - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

octapharma pharmazeutika produktionsges m.b.h - proteinas plÁsmÁticas con al menos 96% de albumina humana - proteinas plÁsmÁticas con al menos 96% de albumina humana....200,00 g

Panama - Inggris - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios compaÑÍa farmacÉutica l.c., s.a. - perÓxido de hidrÓgeno al 50% (h2o2) - perÓxido de hidrÓgeno al 50% (h2o2)....5,9700 g

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: purified talc; gelatin; purified water; colloidal anhydrous silica; magnesium stearate; maize starch; sodium starch glycollate - for the temporary relief of pain associated with headache, toothache, arthritis, osteoarthritis, sore throat, period pain, rheumatic pain, neuralgia, migraine headache, colds and flu, muscular aches and pains. reduces fever.

Arab Saudi - Inggris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

razy al madina pharmaceutical, saudi arabia - valsartan,hydrochlorothiazide - film-coated tablet - 80,12.5 mg,

Arab Saudi - Inggris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

razy al madina pharmaceutical, saudi arabia - valsartan,hydrochlorothiazide - film-coated tablet - 160,12.5 mg,

Arab Saudi - Inggris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

razy al madina pharmaceutical, saudi arabia - valsartan,hydrochlorothiazide - film-coated tablet - 160,25 mg,

Arab Saudi - Inggris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

razy al madina pharmaceutical, saudi arabia - valsartan,hydrochlorothiazide - film-coated tablet - 320,25 mg,

Arab Saudi - Inggris - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

razy al madina pharmaceutical, saudi arabia - valsartan,hydrochlorothiazide - film-coated tablet - 320,12.5 mg,

Yordania - Inggris - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة التقدم للصناعات الدوائية - al-taqqadom pharmaceutical industries - hydralazine hcl 25 mg - 25 mg